Ascentage Pharma Group International Unsponsored ADR (AAPG) Financial Statements

26 Followers

Ascentage Pharma Group International Unsponsored ADR Financial Overview

Ascentage Pharma Group International Unsponsored ADR's market cap is currently $1.91B. The company's EPS TTM is $-13.84; its P/E ratio is -6.64; Ascentage Pharma Group International Unsponsored ADR is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 558.48M	¥ 980.65M	¥ 221.98M	¥ 209.71M	¥ 27.91M
Gross Profit	¥ 426.75M	¥ 951.57M	¥ 191.44M	¥ 187.71M	¥ 24.58M
Operating Income	¥ -1.18B	¥ -369.73M	¥ -872.64M	¥ -849.81M	¥ -869.84M
EBITDA	¥ -1.10B	¥ -237.63M	¥ -743.61M	¥ -786.97M	¥ -798.34M
Net Income	¥ -1.21B	¥ -405.43M	¥ -925.64M	¥ -882.92M	¥ -782.42M
Balance Sheet
Cash & Short-Term Investments	¥ 2.47B	¥ 1.24B	¥ 1.07B	¥ 1.48B	¥ 1.71B
Total Assets	¥ 3.97B	¥ 2.62B	¥ 2.50B	¥ 2.83B	¥ 2.94B
Total Debt	¥ 1.98B	¥ 1.67B	¥ 1.80B	¥ 1.79B	¥ 1.08B
Net Debt	¥ -490.68M	¥ 431.92M	¥ 726.30M	¥ 317.09M	¥ -622.60M
Total Liabilities	¥ 2.63B	¥ 2.34B	¥ 2.43B	¥ 2.42B	¥ 1.71B
Stockholders' Equity	¥ 1.33B	¥ 264.19M	¥ 60.42M	¥ 408.66M	¥ 1.23B
Cash Flow
Free Cash Flow	¥ -1.20B	¥ -135.65M	¥ -782.92M	¥ -890.88M	¥ -1.04B
Operating Cash Flow	¥ -1.17B	¥ -111.36M	¥ -726.08M	¥ -653.91M	¥ -604.68M
Investing Cash Flow	¥ -1.00B	¥ -362.04M	¥ 21.92M	¥ -384.61M	¥ -466.52M
Financing Cash Flow	¥ 2.54B	¥ 314.77M	¥ 368.75M	¥ 619.27M	¥ 1.78B

Currency in CNY

Ascentage Pharma Group International Unsponsored ADR Earnings and Revenue History

Income Statement >

Ascentage Pharma Group International Unsponsored ADR Debt to Assets

Balance Sheet >

Ascentage Pharma Group International Unsponsored ADR Cash Flow

Cash Flow >

Ascentage Pharma Group International Unsponsored ADR Forecast EPS vs Actual EPS

Earnings >